84 / 204
Fima CORPORATION Berhad
(197401004110) (21185-P) •
Annual Report 2020
82
Evaluation Process
Stage 1
Completion of
questionnaires on the
effectiveness of the
Board, Committees and
individual Directors
Stage 2
One-to-one interviews
with each Director to
ensure candid and
objective evaluations
Stage 3
Collation of results
and preparation of a
detailed report on the
findings and actions
Stage 4
Board evaluation
report discussed in
the NRC and the Board
meetings
Stage 5
Areas for continuous
improvements are
recommended to the
Board
III. REMUNERATION
The Board believes that the existing remuneration structure is appropriate for the requirements of the Company, taking into account
factors such as effort and time spent as well as responsibilities of the Directors.
The Board has established guidelines for the Nomination and Remuneration Committee and the Board in determining the level of
remuneration for Executive Director and Non-Executive Directors. The guidelines have been defined in the Terms of Reference of the
Nomination and Remuneration Committee which is available on the Company’s website.
The aggregate amount of remuneration paid to the Directors for FYE2020 is set out below:
Executive
Director
Non-Executive
Directors
Dato’ Roslan
bin Hamir
Dato’ Adnan
bin
Shamsuddin
Rezal
Zain bin
Abdul Rashid
Dr. Roshayati
binti Basir
Rosely
bin Kusip
Datuk Bazlan
bin Osman
RM
Company
Directors Fees
-
81,000
65,000
51,000
55,405
54,475
Meeting allowance
-
24,000
26,000
14,000
22,000
22,000
Salaries
307,800
-
-
-
-
-
Bonus
223,047
-
-
-
-
-
Benefits in kind
27,031
23,866
37,000
-
24,756
15,710
Others
101,791
-
-
-
-
-
TOTAL
659,669
128,866
128,000
65,000
102,161
92,185
Subsidiaries
Directors Fees
-
36,000
36,000
-
-
-
Meeting allowance
-
5,000
4,000
-
-
-
Salaries
461,700
-
-
-
-
-
Bonus
334,566
-
-
-
-
-
Benefits in kind
35,200
-
-
-
-
-
Others
152,278
-
-
-
-
-
TOTAL
983,744
41,000
40,000
0
0
0
In addition to directors’ fees, additional fees are paid to the Chair and members for work carried out by Directors on various Board
Committees to reflect the additional time involved and responsibilities of these positions.
The Company will be requesting shareholders’ approval for the payment of Non-Executive Directors’ fees and benefits-in-kind for the
ensuing financial year and the period commencing from the conclusion of the forthcoming Annual General Meeting (“AGM”) until the
conclusion of the next AGM of the Company in year 2021, respectively. The Company will also be seeking shareholders’ approval on
the increase in fees payable tomembers of the Audit and Risk Committee (excluding the Committee Chairman) from1 April 2020 until
the conclusion of the next AGM of the Company. The justifications on the Directors’ fees and benefits including the increase in Audit
and Risk Committee members’ fees are set out in the Notice of 45
th
Virtual AGM.